FDA Inspection 1078047 - Guilin China Resources Tianhe Pharmaceutical Co., Ltd. - January 11, 2019

Record Details

This FDA Inspection record concerns Guilin China Resources Tianhe Pharmaceutical Co., Ltd., with an inspection on January 11, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Guilin China Resources Tianhe Pharmaceutical Co., Ltd.
Inspection Date: January 11, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 497581b2-9e0b-4df5-9e17-370621d1acb6

Violation Codes2

21 CFR 211.165(e)21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.